Health
Reply to: “Parkinson’s Disease and COVID‐19: Do We Need to Be More Patient?” – Wiley
Click on the article title to read more.
In our paper, Lippi et al1 speculated, early on, on the potential longterm implications of SARSCoV2 infections in the context of neurodegenerative disorders, such as Parkinson’s disease (PD). After ~65 million infections and 1.5 million deaths, we are living unprecedented times. COVID19 changed the way we live, and we are navigating by sight, much like many great explorers in the 15th century. At that time, many doubted the task they set out to do, and many reasoned for caution. In the end, a mix…
-
General24 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business16 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business19 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General16 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips